Publication | Open Access
Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab—a report from the BELOB trial
51
Citations
33
References
2017
Year
In the first 12 weeks, volumetric methods did not provide significant improvement over the RANO criteria as a posttreatment prognostic marker.
| Year | Citations | |
|---|---|---|
Page 1
Page 1